"From $PPCH research they observed that pancreatic proenzymes enforce the re-entry of cancer cells into normal cellular pathways and as such, could represent an exciting new method of managing the disease process," said Dr Julian Kenyon, Chief Scientific Officer of Propanc Health Group http://www.stockwatch.com/News/Item.aspx?bid=U-z10082871-U%3aPPCH-20140521&symbol=PPCH®ion=U
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.